Ligustroflavone exerts neuroprotective activity through suppression of NLRP1 inflammasome in ischaemic stroke mice

  • Authors:
    • Fangfang Bi
    • Ya Bai
    • Yiyong Zhang
    • Wenbo Liu
  • View Affiliations

  • Published online on: November 16, 2022     https://doi.org/10.3892/etm.2022.11707
  • Article Number: 8
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inflammation is thought to play an important role in the pathophysiology of ischaemic stroke, which is a main cause of disability and morbidity worldwide. Inhibition of the NOD‑like receptor protein 1 (NLRP1) inflammasome has been reported to alleviate the inflammatory response in cell and animal models. Ligustroflavone (LIG) is a compound derived from Ligustrum lucidum, which shows anti‑inflammatory activity and may play a beneficial role in a number of neurological diseases. To date, the potential for LIG to act through NLRP1 as a treatment for ischemic stroke has not been studied. The present study established an ischaemic stroke model by middle cerebral artery occlusion (MCAO). Modified neurological severity scoring, open‑field and the Rotarod test were used to assess neurological deficits. Staining with Hoechst 33258 and western blotting were used to evaluate neuronal damage. Expression levels of NLRP1 inflammasome complexes and inflammatory cytokines were determined using western blotting, enzyme‑linked immunosorbent assay and reverse transcription‑quantitative PCR. Treatment with LIG minimized the impairment of neurological function and blocked neuronal damage in MCAO mice. In addition, treatment with LIG attenuated the upregulation of expression levels of the NLRP1 inflammasome complexes and the inflammatory cytokines TNF‑α, IL‑18, IL‑6 and IL‑1β. Overall, LIG played an important role in anti‑inflammatory and neuroprotective activity in MCAO models of ischaemic stroke.
View Figures
View References

Related Articles

Journal Cover

January-2023
Volume 25 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Bi F, Bai Y, Zhang Y and Liu W: Ligustroflavone exerts neuroprotective activity through suppression of NLRP1 inflammasome in ischaemic stroke mice. Exp Ther Med 25: 8, 2023
APA
Bi, F., Bai, Y., Zhang, Y., & Liu, W. (2023). Ligustroflavone exerts neuroprotective activity through suppression of NLRP1 inflammasome in ischaemic stroke mice. Experimental and Therapeutic Medicine, 25, 8. https://doi.org/10.3892/etm.2022.11707
MLA
Bi, F., Bai, Y., Zhang, Y., Liu, W."Ligustroflavone exerts neuroprotective activity through suppression of NLRP1 inflammasome in ischaemic stroke mice". Experimental and Therapeutic Medicine 25.1 (2023): 8.
Chicago
Bi, F., Bai, Y., Zhang, Y., Liu, W."Ligustroflavone exerts neuroprotective activity through suppression of NLRP1 inflammasome in ischaemic stroke mice". Experimental and Therapeutic Medicine 25, no. 1 (2023): 8. https://doi.org/10.3892/etm.2022.11707